Inflammation Cells and Markers

By SWA

What immune cells are involved in inflammation?
During inflammation, macrophages present antigens, undergo phagocytosis, and modulate the immune response by producing cytokines and growth factors. Mast cells, which reside in connective tissue matrices and on epithelial surfaces, are effector cells that initiate inflammatory responses.

Inflammatory responses and inflammation-associated diseases in organs: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805548/

 
What are the markers for inflammatory cells?
The most frequently used inflammatory markers include acute-phase proteins, essentially CRP, serum amyloid A, fibrinogen and procalcitonin, and cytokines, predominantly TNFα, interleukins 1β, 6, 8, 10 and 12 and their receptors and IFNγ.
Inflammatory markers explained: https://arc-w.nihr.ac.uk/news/inflammatory-markers-explained/
 

What cell is elevated during chronic inflammation?
Of the cell types present in chronic inflammation, macrophages are the most important as they secrete a large collection of biologically active products. These products have a key role in promoting the growth of fibroblasts and blood vessels, as well as tissue regeneration and remodeling.
Chronic Inflammation: https://www.sciencedirect.com/topics/medicine-and-dentistry/chronic-inflammation
 
 
What are the 5 markers of inflammation?
Based on visual observation, the ancients characterised inflammation by five cardinal signs, namely redness (rubor), swelling (tumour), heat (calor; only applicable to the body' extremities), pain (dolor) and loss of function (functio laesa).
"The Journal of Inflammation": https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1074343/
 

Cascade of immune mechanism and consequences of inflammatory disorders: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373857/

  Inflammatory Cascade: Pathogenesis and Clinical Findings ...

The immune system and inflammatory markers are closely interrelated, each playing a significant role in the body's response to infections, injuries, and diseases. Here's a brief overview of their relationships:

  1. Immune System Cells and Inflammatory Markers: The immune system is composed of various cells like T-cells, B-cells, macrophages, and neutrophils. These cells release inflammatory markers, such as cytokines and chemokines, in response to pathogens or tissue damage.

  2. Cytokines: These are small proteins released by immune cells that have a significant role in cell signaling. Cytokines like interleukins (ILs), tumor necrosis factor (TNF), and interferons (IFNs) are critical in mediating and regulating immunity, inflammation, and hematopoiesis.

  3. Acute Phase Reactants: These are proteins whose plasma concentrations increase (positive acute-phase proteins) or decrease (negative acute-phase proteins) in response to inflammation. Examples include C-reactive protein (CRP), which is a commonly used clinical marker to assess the presence and intensity of inflammation.

  4. Chemokines: These are a subset of cytokines that specifically direct the movement of circulating immune cells to the site of injury or infection.

  5. Interplay in Disease: In many diseases, an imbalance in these markers can lead to pathological conditions. For instance, in autoimmune diseases, inappropriate activation of the immune system causes an excessive inflammatory response. Similarly, chronic inflammation is a hallmark of many diseases like rheumatoid arthritis, where both immune cells and inflammatory markers play a role.

  6. Feedback Mechanisms: The immune response and inflammation are tightly regulated by feedback mechanisms. Certain cytokines can promote inflammation (pro-inflammatory cytokines), while others play a role in reducing inflammation and promoting healing (anti-inflammatory cytokines).

  7. Therapeutic Targets: Many modern therapeutics aim to modulate these markers. For example, biologics used in autoimmune diseases target specific cytokines or their receptors to reduce inflammation and immune system activity.

 Immunology | Inflammation: Vascular Events: Part 1: https://www.youtube.com/watch?v=LArxUakFsFs&t=2s

Comments

Post a Comment

Popular posts from this blog

Is ME CFS Spinal Muscular Atrophy (SMA)?

By SWA
After a 70-year journey filled with multiple incorrect diagnoses and just as many inappropriate treatments, I finally found an answer to my progressive muscle weakness. Throughout this time, I faced insults and was labeled lazy for my inability to walk long distances or up hills, climb steps, or carry heavy loads. I couldn't ride a bike because sitting on the saddle was impossible. My school grades suffered due to insufficient performance in sports. Instead of receiving comfort from my parents, I was pushed into hard work to strengthen my muscles. Doctors also advised me to exercise my muscles. My life continued with reduced activity, as I had to avoid or quit jobs where standing for extended periods was required or where I couldn't support my skeletal muscle weakness by bracing my elbows. The most excruciatingly painful and weakest period, when I could barely walk, occurred at age 20, during pregnancy. In 2008, an MRI referred by my endocrinologist for permanent adrenal
Read more

Cytokine Storm, Mast Cell Activation Syndrome (MCAS), Endothelial Dysfunction and microclots/thrombosis?

By SWA
Image
Could a virus be the stimulus for cytokine production?   It is well established, but rarely  tested, that a cytokine storm is an overactive immune response characterized by the excessive release of pro-inflammatory cytokines. ( ANA, CRP, and CBC tests are necessary) It can occur in various conditions, such as severe infections (e.g., COVID-19), (and other viruses), autoimmune diseases, and after certain treatments.  Serositis and lymphopenia are common features of systemic lupus erythematosus following SARS-CoV-2 infection: A case report and literature review These cells are called NKG2D+CD8+ T cells and researchers say their aggressive response is responsible for neurological damage suffered from infections beyond just Zika, like COVID-19 and even septic shock. The aggressive response is the result of the body producing large amounts of inflammatory proteins called cytokines, which in moderation help to coordinate the body’s response in battling an infection or injury by
Read more

WASF3 updated and additional information

By SWA
Image
  WASF3 disrupts mitochondrial respiration and may mediate exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome Significance​ Chronic fatigue is a debilitating symptom that affects many individuals, but its mechanism remains poorly understood. This study shows that endoplamic reticulum (ER) stress–induced WASF3 protein localizes to mitochondria and disrupts respiratory supercomplex assembly, leading to decreased oxygen consumption and exercise endurance. Alleviating ER stress decreases WASF3 and restores mitochondrial function, indicating that WASF3 can impair skeletal muscle bioenergetics and may be targetable for treating fatigue symptoms. Abstract​ Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is characterized by various disabling symptoms including exercise intolerance and is diagnosed in the absence of a specific cause, making its clinical management challenging. A better understanding of the molecular mechanism underlying this apparen
Read more